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HIV-1 MOTHER-TO-CHILD TRANSMISSION AND ASSOCIATED CHARACTERISTICS IN A PUBLIC 
MATERNITY UNIT IN PRESIDENTE PRUDENTE, BRAZIL
Luiz Euribel PRESTES-CARNEIRO(1), Patrícia Rodrigues Naufal SPIR(2,3), Armênio Alcântara RIBEIRO(2) & Vera Lúcia Maria Alves GONÇALVES(4)
SUMMARY
In children, vertical transmission is the main form of HIV infection. Our aim was to determine the prevalence of HIV-1 vertical 
transmission in mother-infant pairs in a public maternity ward in Presidente Prudente, SP. Additionally; we sought to identify 
characteristics associated with this form of transmission. The files of 86 HIV-1-infected mothers and their newborns referred to a 
Public Hospital from March 2002 to March 2007 were analyzed. The HIV-1-RNA viral load of the newborns was determined by 
bDNA. The HIV-1 vertical-transmission rate was 4.6%. Children that were born in the pre-term period and breastfed were at a higher 
risk of HIV-1 infection (p = 0.005 and p = 0.017 respectively) than children born at term and not breastfed. Prophylactic therapy with 
zidovudine after birth for newborns was associated with a lower risk of infection (p = 0.003). The number of newborns weighing < 
2,500 g was significantly higher for infected children (p = 0.008) than for non-infected newborns. About 22.9% of mothers did not 
know the HIV-1 status of their newborns eight months after delivery. The study suggests that it is necessary to increase the identification 
of HIV-1 infection in pregnant women and their newborns as well as to offer and explain the benefits of ARV prophylaxis.
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INTRODUCTION
About one third of all people living with HIV in Central and South 
America live in Brazil. In Latin America, although epidemiological data 
suggest that the HIV-1 epidemic has remained stable in the region, during 
the last decade there has been an increase in the incidence of HIV/AIDS 
among women of reproductive age (UNAIDS, 2010). In children, vertical 
transmission is the main form of infection and can occur during late 
pregnancy, during delivery or post-partum through breastfeeding (ORNE-
GLIEMANN et al., 2008). Brazil was one of the first developing countries 
to implement measures to prevent mother-to-child transmission (MTCT) 
of HIV-1, resulting in a decrease in vertical transmission rates (PN-DST/
AIDS, 2006; AMARAL et al., 2007; PRESTES-CARNEIRO et al., 
2009). There are limited data addressing the prevalence and risk factors 
of MTCT in the western region of the São Paulo State (GONÇALVES 
et al., 2011). A recent study showed a growing AIDS dissemination 
among females in small-sized municipalities in the state (PRADO & 
CASTILHO, 2009). The objective of this study was to determine HIV-
1 vertical transmission rates and some characteristics associated with 
MTCT in a public maternity ward located in the western region of the 
São Paulo State.
MATERIAL AND METHODS
Patients and samples: Located in the western part of Southeast 
Brazil, the Regional Health Department of Presidente Prudente (DRS 
XI) is composed of 45 municipalities, with approximately 750,000 
inhabitants living mainly in small cities and rural communities. Located 
in Presidente Prudente, the Public Hospital Dr. Odilo Antunes Siqueira 
(PH) is a regional public maternity ward to which most pregnant women 
and women in the intrapartum period who are infected or at risk of HIV-
1 infection are referred. The city also harbors the Adolfo Lutz Institute 
(ALI), the public reference laboratory responsible for confirming HIV-1 
tests as well as measuring viral-load counts in HIV-1-positive pregnant 
women and infant-pairs of DRS XI.
For this retrospective study, the files of mother-infant pairs born in 
the maternity ward of the PH from March 2002 to March 2007 - those 
whose blood samples were analyzed by the Molecular Biology Unit, 
in the Medical Biology Section of ALI, for HIV-1-RNA viral load 
determination, with the aim of assisting in the diagnosis of MTCT - 
were reviewed. The inclusion criteria were: children up to 18 months 
of age at the time of the first HIV-1-RNA viral load determination, and 
children that have undergone at least two blood samples for HIV-1-RNA 
viral load determination.
HIV-1-RNA analysis - Quantification of HIV-1-RNA was performed 
in plasma using the VERSANT® HIV-1 RNA 3.0 Assay (bDNA) 
(Bayer Corporation, Emervylle, California, USA) in accordance with 
the manufacturer’s instructions. The assays were performed twice after 
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a follow-up period of at least eight months between the first visit and 
the follow-up analysis. Newborns were considered uninfected if at least 
two independent blood samples were below the limit of detection of the 
HIV-1-RNA quantification test. Children were considered infected when 
at least two independent blood samples were positive in HIV-1-RNA 
quantification tests.
All of the women were hospitalized in the intrapartum period by the 
Unified National Health System (SUS).
The risk factors explored in the obstetric category were as follows: 
number of pregnancies, age groups, gestational age, mode of delivery and 
breastfeeding. The characteristics of infants analyzed were as follows: 
birth weight, birth width, use of zidovudine neonatal prophylaxis, use of 
trimethoprim/sulfamethoxazole (TMT/SMZ), and time of first analysis of 
the HIV-1 viral load of babies after birth. Antiretroviral (ARV) therapies 
were described as Zidovudine Monotherapy, dual Nucleoside Reverse 
Transcriptase Inhibitor therapy (NRTI, ZDV plus another NRTI), and 
Highly Active Antiretroviral Therapy (HAART; two NRTI plus one 
Non-Nucleoside Reverse Transcriptase Inhibitor - NNRTI; two NRTI 
plus one Protease Inhibitor - PI). Some women did not use any therapy 
during gestation or labor and delivery. This protocol was in accordance 
with the Brazilian STD/AIDS program3 and was approved by the Ethics 
Committee of ALI, SP, Brazil.
Statistical analysis - Fisher’s exact test and the chi-square test were 
used to analyze the data using GraphPad Instat software (V4.0, San 
Diego, CA) and GraphPad Prism (V4.0, San Diego, CA). All p values are 
two-tailed; p values < 0.05 were considered to be statistically significant. 
Vertical HIV-1 transmission was calculated as the ratio of the number of 
newborns with a known HIV-1-positive diagnosis, divided by the total 
number of newborns.
RESULTS
From March 2002 to March 2007, 96 births of HIV-1-infected 
mothers occurred in the maternity ward of the PH, and blood samples 
of these newborns were analyzed by ALI for HIV-1-RNA determination. 
The analysis of the files of mother-infant pairs revealed that no twin 
births occurred. One child died during the neonatal period with two 
positive blood samples for HIV-1-RNA. Nine newborns were lost during 
the follow-up for different reasons such as transfer from the region of 
Presidente Prudente, lack of a second blood sample for HIV-1-RNA 
determination, children older than eighteen months for the first HIV-
1-RNA analysis or few data in the records of mother-infant pairs. Data 
were available for 86 mother-infant pairs who completed the inclusion 
criteria established to prevent MTCT of HIV-1. The overall vertical HIV-1 
transmission rate was 4.6% (4/86), (CI 1.28–11.48), with no differences 
in infection relating to the sex of the infant. In this study, 12% of mothers 
brought their children for HIV-1 determination before they reached two 
months of age, 47.70% between two and four months, 10% between 
five and six months, 7.4% between seven and eight months and 22.9% 
over eight months of age. The distribution of births during the period 
was as follows: March 2002 to March 2003, 21% (18/86); April 2003 to 
March 2004, 27.9% (24/86); April 2004 to March 2005, 19.8% (17/86); 
April 2005 to March 2006, 13.9% (12/86) and from April 2006 to March 
2007, 17.4% (15/86).
The risk factors were determined in 86 mothers referred to the Public 
Hospital (PH) during this period, although some data were missing in 
several of the files. Of the 86 files analyzed, 61.6% of the mothers lived 
in Presidente Prudente and 38.4% were from other cities of the DRS 
(Regional Health Directory) XI.
Table 1 shows that children who were born in the preterm period (< 
37 weeks of gestational age) had a higher risk of HIV-1 infection than 
children who were delivered at term (≥ 37 weeks of gestational age) (p 
= 0.005). Not-breastfeeding was associated with a protection against 
infection in newborns (p = 0.017). Maternal age at the time of delivery 
varied from 15 to 40 years (mean 27.8; 95% CI 26.34 - 29.36 years), 
and only one mother was under 18 years old. No difference in MTCT 
related to maternal age was found. Elective cesareans and the number of 
pregnancies also did not correlate with HIV-vertical transmission (p > 
0.05). Elective cesareans were conducted in 76.8% (53/69) of mothers. 
Zidovudine prophylaxis was administered to 33.3% (20/60) of mothers, 
and 13.3% (8/60) did not receive zidovudine.
Table 2 shows the infant follow-up. Newborns < 2,500 g at birth had 
a significantly higher rate of HIV-1 transmission than those > 2,500 g (p 
= 0.008). In this study, prophylactic therapy with zidovudine in neonates 
was associated with a lower risk of infection (p = 0.003). Regarding 
timing of HIV-1 diagnosis, of 86 mothers analyzed, only 44 files showed 
this information, of which 50% (22/44) documented diagnosis before 
antenatal care, 40.9% (18/44) during antenatal care, and 9.1% (4/44) 
during or after delivery.
After delivery, mothers were instructed to take their babies to an 
infectious-disease specialist, and 70.4% (50/71) visited the doctor less 
than two months after delivery. The number of visits to the specialist 
during the first year of life was distributed as follows: 16.4% (11/67) 
Table 1
Characteristics of HIV-1-infected woman related to mother-to-child 
transmission in a Public Maternity Ward in Presidente Prudente, Brazil




P 0R CI 95%
No. of pregnancies
     2 or fewer




1 0.30 4.56 0.44-46.64
Age groups
     16-29




1 1.0 1.31 0.11-15.30
Gestational age
     Term




3 0.005 31.2 2.71-358.95
Mode of delivery
   Vaginal delivery
   Elective-cesarean




3 1.000 0.90 0.08-9.30
Breastfeeding
     Yes




2 0.017 28.5 2.54-318.92
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visited fewer than two times, 53.7% (36/67) visited three to five times, 
and 29.8% (20/67) visited the clinic six to nine times.
Figure 1 shows the antiretroviral schema used among HIV-1-infected 
woman during pregnancy. Among 86 mothers analyzed during the 
period, only 60 files showed these data, from which 13.3% (8/60) did 
not use antiretroviral drugs, 33.3% (20/60), used the Nucleoside Analog 
Inhibitor (NRTI) zidovudine as a monotherapy and 8.3% (5/60) used 
a dual therapy with a combination of two drugs from the same group 
(NRTI). As a HAART regimen, with a combination of three or more 
drugs, 18.3% (11/60) used NRTI and Non-Nucleoside Analog Inhibitors 
(NNRTI). NRTI plus protease inhibitors (PI) were administered to 26.7% 
(16/60) of mothers.
DISCUSSION
Primary public healthcare centers and regional reference hospitals 
distributed throughout Brazilian municipalities represent a key role in 
the screening, diagnosis and management of populations considered 
to be at-risk of blood-borne diseases such as HIV-1 (PORTELINHA 
FILHO et al., 2009). The overall prevalence rate of vertical transmission 
of HIV-1 in this study was 4.6%. This rate is lower than that found in a 
nationwide multicenter study (7.1%), (CI 1.3-11.5 p > 0.05), conducted 
in 2001 (MENEZES SUCCI, 2007). In Brazil, the prevalence of HIV-1 
vertical transmission has declined in the last decade due to global and 
regional measures implemented by the PN-DST/AIDS program (PN-
DST/AIDS, 2006, UNAIDS, 2010). Limited by a reduced number of 
patients (86 pregnant and four positive mother-infant pairs) our data are 
in some aspects similar to the results obtained in other big cities and 
regions of Brazil (AMARAL et al., 2007; MENEZES SUCCI, 2007).
In this study, breastfeeding is found to be one of the main risk 
factors for maternal HIV-1 vertical transmission (Table 1). Infected 
mothers were advised not to breastfeed their infants and offered clinical 
or pharmacological support, as recommended by Government Protocol 
(UNAIDS, 2010). The government also provided specific nutritional 
formula. However, four mothers breastfed their babies, leading to a 
significant increase in HIV-1 vertical transmission in this group. There 
is specific evidence regarding the association between breastfeeding 
and MTCT. The occurrence of MTCT is 15-30% in non-breastfeeding 
populations. The risk increases considerably to 20-45% among 
populations who practice prolonged breastfeeding (AMARAL et al., 
2007; ORNE-GLIEMANN et al., 2008).
The classic study conducted by the Pediatric AIDS Clinical Trials 
Group Protocol (PACTG 076), showed that MTCT can be reduced 
significantly through maternal antiretroviral treatment during pregnancy 
and delivery and infant antiretroviral prophylaxis after birth (CONNOR 
et al., 1994). The efficacy of a short-course peri-partum of the ARV-
zidovudine prophylaxis regimen administered to HIV infected pregnant 
mothers and their newborns has been established in Brazil since 1996 
(BRITO et al., 2005; PN-DST/AIDS, 2006). Regrettably, eight mothers 
(13.3%), and consequently their infants, did not receive zidovudine or 
ARV prophylaxis. Although the reasons for the lack of prophylaxis were 
not determined, one possibility is the fact that 9.1% of the analyzed 
mothers did not know their HIV-1 status before labor and delivery. 
The percentage is similar to recent data (6.6%) obtained from pregnant 
women at a Public Teaching Hospital in Presidente Prudente (PRESTES-
CARNEIRO et al., 2009). Among the pregnant women who used ARV 
in the gestation or delivery period, ZDV monotherapy represented 
33.3% and HAART (NRTI+PI) represented 23.3%. These data are in 
accordance with the protective effect of ZDV regarding the reduction of 
vertical transmission (CONNOR et al., 1994; AMARAL et al., 2007; 
ORNE-GLIEMANN et al., 2008).
To reduce the number of pregnant women not tested during antenatal 
care or whose HIV-1 status is undocumented during labor and delivery, 
a nationwide PN-STD/AIDS program of rapid HIV-1 testing was one 
of the main strategies introduced (PN-DST/AIDS, 2006; PRESTES-
CARNEIRO et al., 2009). Despite all the planning and policy-making, 
the lack of decentralized services, the high number of women referred 
from small cities and rural areas and the continuous lack of rapid HIV-1 
Table 2 
Variables related to HIV-1 vertical transmission in infants in a Public Maternity 
Ward in Presidente Prudente, Brazil




P OR CI 95%
Birth weight 
(grams) 
      > 2500 g 




3 0.008 24.42 2.22-268.21
Birth width 
     <  45 cm




2 0.156 5.0 0.62-39.81
ZDV neonatal
         Yes




3 0.003 39.0 3.26-466.54
TMP/SMZ
     No 




3 0.21 6.88 0.54-87.62
(ZDV: zidovudine; TMP/SMZ: Trimethoprim/Sulfamethoxazole).
Fig. 1 - Antiretroviral regimen. Dual nucleoside reverse transcriptase inhibitor therapy 
(NRTI, ZDV plus another NRTI), and highly active antiretroviral therapy (HAART; two 
NRTI plus one non-nucleoside reverse transcriptase inhibitor-NNRTI; two NRTI plus one 
protease inhibitor-PI).
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test kits can contribute to missed opportunities for preventing MTCT. In 
accordance with this hypothesis, 38.4% of women were referred from 
small cities of DRS XI. These results demonstrate the delicate nature of 
operating a public health system in the region during the period analyzed.
In these data, with regard to gestational age, premature babies had a 
higher risk of HIV-1 infection than full-term babies. Pre-term delivery 
and low birth weight were common among women on HAART during 
pregnancy, especially when therapy was started before or during the first 
trimester of pregnancy (ORNE-GLIEMAN et al., 2008). However, it was 
not possible to link prematurity and HIV-1 infection with ARV because 
we do not know in which period of pregnancy the ARV therapy occurred.
The growing number of pregnancies in adolescents and young 
women in Brazil in recent decades is alarming (ROCHA et al., 2010). 
Interestingly, only one of the mothers was under the age of 18, and the 
group’s median age was 27.8 years. These findings suggest that, at least in 
this region, either HIV-1 infection is occurring after adolescence or young 
women are able to postpone or even avoid pregnancy, a theory supported 
in a Brazilian multicentric study of MTCT (MENEZES SUCCI, 2007). 
In contrast to the results reported herein, a study conducted in the Mato 
Grosso do Sul State, a surrounding DRS XI area, found that 19.8% of 
HIV-1 pregnant women were youths (DAL FABRO et al., 2005). In the 
data presented herein, the number of previous pregnancies, antenatal care 
visits and vaginal deliveries were not associated with HIV-1 maternal 
transmission. Vaginal delivery is strongly associated with an elevated 
risk of HIV-vertical transmission particularly in mothers with low levels 
of CD4+T lymphocytes and elevated HIV-viral load counts (ORNE-
GLIEMANN et al., 2008; KAKEHASI et al., 2008). Regarding the mode 
of delivery, elective cesarean sections were performed in 76.8% of the 
pregnancies, independent of previous ARV regimen or viral-load counts, 
reflecting the high frequency of cesarean sections performed in Brazil 
(MENEZES SUCCI, 2007). It is currently accepted that for women with 
ARV treatment in gestation and elevated CD4+ levels, elective cesarean 
has no effect on HIV-1 transmission (ORNE-GLIEMANN et al., 2008).
The major factors governing MTCT can be broadly classified as 
maternal, obstetrical and neonatal (ORNE-GLIEMANN et al., 2008). 
Among the neonatal characteristics associated with HIV-1 vertical 
transmission (Table 2), the present study analysis of the data demonstrates 
the protective effect of starting AZT prophylaxis immediately after birth, 
as recommended by the PN-DST/AIDS program in reducing MTCT. 
Several studies have indicated that even incomplete AZT regimens were 
effective in protecting newborns from HIV infection (JOÃO et al., 2003; 
MUSSI-PINHATA et al., 2007). In addition, the association between low 
birth weight and the HIV transmission observed has also been reported by 
others, linked mainly to poor nutritional status, anemia or low maternal 
body mass index. Low birth weight was found to be an important factor 
in predicting infant death (MEHTA et al., 2008).
Infectious diseases account for nearly 90% of early childhood deaths 
in developing countries (MUSSI-PINHATA et al., 2007). In this study, 
93% of infants received trimethoprim/sulfamethoxazole in the neonatal 
period for prophylaxis against Pneumocystis jiroveci pneumonia. Only 
one death occurred in the neonatal period. According to the instructions 
of the Brazilian Ministry of Health HIV-AIDS program, the viral load of 
newborns should be determined at both two and four months following 
delivery. It should be noted that about 22.9% of mothers did not bring 
their babies for HIV-1-RNA determination eight months after delivery. 
The earliest possible screening for the HIV-1 viral status of newborns 
constitutes a key event in the follow-up of infants. One possibility is the 
distance between some counties or suburbs where many mothers live 
and the PH. However, an efficient public transport system for patients 
from other municipalities to referral centers such as PH is available in 
the region.
Because we only investigated mother-infant pairs referred to PH, the 
results drawn from this observational study may not be representative of 
HIV-infected women throughout the region. However, this limitation can 
be attenuated by the fact that PH is the only referral center for at-risk or 
HIV-1-infected pregnant women in the DRS XI area (CREMONEZI et al., 
2005; ALVES et al., 2009). In this respect, the study involved 81% of all 
mother-infant pairs screened for MTCT who were referred to the Adolfo 
Lutz Institute (ALI), between 2002 and 2007. Another limitation of this 
study is the under-powered number of patients, precluding multivariate 
analysis. Nevertheless, the analyzed data could be used in the future to 
improve and compare the effectiveness of the measures adopted.
In conclusion, national and regional public-health policies were 
implemented in the last few years to prevent and control the vertical 
transmission of HIV. However, in the DRS XI region, the study suggests 
that it is necessary to increase the identification of HIV-1 infection in 
pregnant women and their infants as well as to offer and explain the 
benefits of ARV prophylaxis. Otherwise, in line with an observation made 
by Kallings (2008), we may win the battles, but we will lose the war.
RESUMO
Transmissão vertical do HIV e características associadas em 
maternidade pública em Presidente Prudente, Brasil
A transmissão vertical é a principal forma de infecção pelo HIV em 
crianças. Nosso objetivo foi determinar a prevalência da transmissão 
vertical do HIV em maternidade pública em Presidente Prudente, SP. 
Além disso, procuramos identificar características associadas a essa 
forma de transmissão. De março de 2002 a março de 2007, os prontuários 
de 86 mães HIV-1 positivo e seus bebês, nascidos na maternidade de 
Hospital Público foram analisadas. A carga viral do HIV-1-RNA dos 
recém-nascidos foi determinada por bDNA. A prevalência da transmissão 
vertical pelo HIV-1 foi de 4,6%. Crianças nascidas a pré-termo e 
amamentadas tiveram um risco maior de infecção (p = 0,005 e p = 
0,017, respectivamente), comparado com crianças nascidas a termo e 
não amamentadas. A profilaxia com zidovudina depois do nascimento 
para os recém-nascidos foi associada ao menor risco de infecção (p = 
0,003). O número de recém-nascidos com peso < 2.500 g foi maior 
entre as crianças infectadas (p = 0,008), comparado com crianças não 
infectadas. Oito meses depois do parto 22,9% das mães não tinham 
conhecimento da infecção de seus bebês pelo HIV. O presente estudo 
sugere a necessidade em aumentar a identificação do HIV em gestantes e 
seus bebês e explicar e oferecer os benefícios da profilaxia antiretroviral. 
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